ESM1 and endothelial dysfunction: Since it has been shown that knockdown of endocan attenuate the PAH related changes in a rat model of CTD-PAH via inhibition of TNF-α related inflammation pathways [17], it could be hypothesized that endocan may participate in the pathogenesis of preeclampsia via enhancing inflammation related endothelial dysfunction.